SB-505124 Hydrochloride: Precision Tool for Fibrosis Researc
2026-07-15
SB-505124 hydrochloride empowers researchers to dissect TGF-β/activin signaling with exceptional selectivity and reproducibility, making it a gold-standard inhibitor in fibrosis and mechanotransduction studies. Its robust solubility and non-cytotoxicity facilitate seamless integration into advanced protocols, while recent mechanobiology insights reveal new pathways for experimental innovation.
Ceramide Metabolism Drives RGNNV Infection: Lipidomics Insig
2026-07-15
This study reveals how red-spotted grouper nervous necrosis virus (RGNNV) manipulates ceramide metabolism to promote its replication via autophagy in fish cells. The findings highlight the central role of ceramides in viral pathogenesis and suggest new avenues for antiviral strategies targeting sphingolipid pathways.
25-Hydroxycholesterol Drives Macrophage Immunosuppression vi
2026-07-14
Xiao et al. (2024) reveal that 25-hydroxycholesterol (25HC) accumulates in tumor-associated macrophages (TAMs), activating AMP kinase (AMPK) and reprogramming macrophage metabolism to enhance immunosuppressive functions. Targeting the CH25H-25HC-AMPK-STAT6 pathway reshapes the tumor microenvironment, improving anti-tumor T cell responses and synergizing with anti-PD-1 therapy.
JNJ-10198409: Illuminating PDGF Inhibition for Next-Gen Dise
2026-07-14
Explore the scientific foundation and translational promise of JNJ-10198409, a potent platelet-derived growth factor receptor inhibitor. This in-depth analysis reveals unique cross-domain implications and assay design strategies, setting it apart from existing guides.
Migratory Interneuron Precursors for Glioma Therapy: Study I
2026-07-13
The referenced study pioneers the use of migratory cortical inhibitory interneuron precursors (MCIPs) as cellular vectors for targeted delivery of bispecific T-cell engagers (BiTEs) to high-grade gliomas. This approach addresses major delivery barriers in brain tumor therapy, offering a platform for localized immune modulation and potential extension of survival in preclinical models.
Low-Molecular Weight Inhibitors Targeting Alternative Comple
2026-07-13
This review elucidates the development of low-molecular weight inhibitors, especially those targeting complement factor B and D, for selective modulation of the alternative complement pathway. The findings highlight advances in oral inhibitors and their translational potential for complement-mediated diseases, providing a foundation for both experimental and therapeutic research.
3-Deazaadenosine Hydrochloride: Unraveling Methylation in Li
2026-07-12
Explore how 3-Deazaadenosine hydrochloride, a potent S-adenosylhomocysteine hydrolase inhibitor, enables advanced dissection of methylation-dependent mechanisms in hepatic stellate cell activation and liver fibrosis. This in-depth analysis integrates recent m6A regulatory breakthroughs and offers unique practical assay guidance.
EMD638683 (SGK1 Inhibitor): Unraveling Vascular Stiffening M
2026-07-10
Explore how EMD638683, a selective SGK1 inhibitor, enables advanced vascular and hypertension research by dissecting the molecular mechanisms of endothelial stiffening. Discover practical insights for assay design, bridging mechanistic depth with translational potential.
Modeling Human Pacemaker Maturation with SAN-Plexus Assemblo
2026-07-09
This study introduces a human in vitro platform integrating sinoatrial node and cardiac plexus organoids to model neuron-driven pacemaker maturation. By leveraging spatial transcriptomics and functional interrogation, the work uncovers a prosaposin-GPR37 signaling axis essential for human SAN development, with implications for cardiac disease modeling and translational research.
Applied Use of EMD638683: Precision SGK1 Inhibitor Workflows
2026-07-09
EMD638683 stands apart as a highly selective SGK1 inhibitor, enabling precise dissection of sodium channel regulation and actin dynamics in cardiovascular and oncology research. This guide translates recent landmark findings into actionable protocols, troubleshooting tips, and advanced applications for maximizing the impact of EMD638683 in experimental designs.
Cardamomin Attenuates Oxidative Damage in Ischemic Stroke Mo
2026-07-08
This study demonstrates that cardamomin, a chalcone from Amomum villosum, confers neuroprotection against oxidative stress and reduces infarct size in cellular and animal models of ischemic stroke. Mechanistic insights reveal that cardamomin modulates NRF2 signaling and cell death pathways, offering translational potential for cerebral ischemic injury research.
SMYD2 Inhibition Mitigates Cisplatin-Induced Renal Fibrosis
2026-07-08
This study identifies SMYD2 as a key regulator of cisplatin-induced renal fibrosis and inflammation, demonstrating that pharmacological inhibition of SMYD2 protects against chronic kidney disease in experimental models. These findings highlight a promising epigenetic target for limiting nephrotoxicity in cisplatin-based cancer therapy.
Phosbind Biotin: Dinuclear Metal Complex for Western Blot De
2026-07-07
Phosbind Biotin leverages dinuclear metal complex phosphate binding to enable sequence-independent, highly sensitive detection of phosphorylated proteins in Western Blots. Its robust performance streamlines workflows in plant stress signaling and disease research, offering a reliable alternative to phospho-specific antibodies.
Prestained Protein Marker (Triple color, EDTA free, 10-250 k
2026-07-07
The Prestained Protein Marker (Triple color, EDTA free, 10-250 kDa) provides a reliable SDS-PAGE molecular weight standard for protein sizing and transfer verification, avoiding EDTA interference. It is best suited for standard electrophoresis, Phosbind SDS-PAGE, and fluorescent membrane imaging, but is not intended for applications requiring unstained or highly sensitive quantitation.
XAV-939: Potent Tankyrase Inhibitor for Wnt/β-Catenin Modula
2026-07-06
XAV-939 (NVP-XAV939) is a nanomolar tankyrase 1/2 inhibitor that disrupts Wnt/β-catenin signaling by stabilizing axin and promoting β-catenin degradation. This compound is widely adopted in cancer research, bone formation disorder studies, and fibrotic disease models. APExBIO supplies XAV-939 (SKU A1877) as a highly pure solid, optimized for reproducible experimental workflows.
461 records 12/31 page Previous Next First page 上5页 1112131415 下5页 Last page